TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment

Archive ouverte

Zizza, Pasquale | Dinami, Roberto | Porru, Manuela | Cingolani, Chiara | Salvati, Erica | Rizzo, Angela | d'Angelo, Carmen | Petti, Eleonora | Amoreo, Carla, Azzurra | Mottolese, Marcella | Sperduti, Isabella | Chambery, Angela | Russo, Rosita | Ostano, Paola | Chiorino, Giovanna | Blandino, Giovanni | Sacconi, Andrea | Cherfils-Vicini, Julien | Leonetti, Carlo | Gilson, Eric | Biroccio, Annamaria

Edité par CCSD ; Oxford University Press -

International audience. The telomeric protein TRF2 is overexpressed in several human malignancies and contributes to tumori-genesis even though the molecular mechanism is not completely understood. By using a high-throughput approach based on the multiplexed Luminex X-MAP technology, we demonstrated that TRF2 dramatically affects VEGF-A level in the secretome of cancer cells, promoting endothelial cell-differentiation and angio-genesis. The pro-angiogenic effect of TRF2 is independent from its role in telomere capping. Instead, TRF2 binding to a distal regulatory element promotes the expression of SULF2, an endoglucosamine-6-sulfatase that impairs the VEGF-A association to the plasma membrane by inducing post-synthetic modification of heparan sulfate proteoglycans (HSPGs). Finally, we addressed the clinical relevance of our findings showing that TRF2/SULF2 expression is a worse prognostic biomarker in colorectal cancer (CRC) patients.

Suggestions

Du même auteur

TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells

Archive ouverte | Biroccio, Annamaria | CCSD

International audience. Dysfunctional telomeres suppress tumour progression by activating cell-intrinsic programs that lead to growth arrest. Increased levels of TRF2, a key factor in telomere protection, are observ...

Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2

Archive ouverte | Cherfils-Vicini, Julien | CCSD

International audience. Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells with strong immunosuppressive activity that promote tumor growth. In this study, we describe a mechanism by which cancer ce...

TRF2 and Apollo Cooperate with Topoisomerase 2α to Protect Human Telomeres from Replicative Damage

Archive ouverte | Ye, Jing | CCSD

Human telomeres are protected from DNA damage by a nucleoprotein complex that includes the repeat-binding factor TRF2. Here, we report that TRF2 regulates the 5′ exonuclease activity of its binding partner, Apollo, a member of the...

Chargement des enrichissements...